Month: March 2022

VPR Brands Announces Favorable Settlement of Third Patent Infringement Case; Settlements Now Total Over $500,000

Written by Customer Service on March 25, 2022. Posted in Public Companies.

VPR Brands Announces Favorable Settlement of Third Patent Infringement Case VPR Brands announces favorable settlement of third patent infringement case; settlements now total over $500,000.FORT LAUDERDALE, Fla., March 25, 2022 (GLOBE NEWSWIRE) — via InvestorWire — VPR Brands, LP (OTC: VPRB): VPR Brands is a market leader and pioneer in electronic cigarettes and vaporizers for nicotine, cannabis and cannabidiol (CBD). On March 18, 2022, the Company entered into a Settlement Agreement (the “XL Settlement Agreement”) by and between the Company on the one hand, and XL Vape, LLC (“XL”), VGOD LLC (“VGOD”), and Saltnic LLC (“Saltnic” and collectively with XL and VGOD, the “XL Parties”), on the other hand. The Company previously filed a lawsuit in the United States District...

Annual Shareholders’ Meeting Update

Written by Customer Service on March 25, 2022. Posted in Public Companies.

TORONTO, March 25, 2022 (GLOBE NEWSWIRE) — Fairfax Financial Holdings Limited (“Fairfax”) (TSX: FFH and FFH.U) announces that it will be hosting its annual shareholders’ meeting both in-person and virtually, as originally announced, on Thursday, April 21, 2022. Our expectation is that all of our Presidents will be attending the meeting in-person to greet our guests and to answer any questions. For those travelling to attend the meeting, we are pleased to share that, effective April 1, 2022, fully vaccinated travellers arriving to Canada will no longer need to provide pre-entry COVID-19 test results. Fairfax will advise of further details on the meeting, including how to send questions in advance, in a later announcement. Fairfax is a holding company which, through its subsidiaries, is primarily engaged in property and casualty...

Lifeist Reports Fourth Quarter and Full Year 2021 Financial Results

Written by Customer Service on March 25, 2022. Posted in Earnings Releases And Operating Results.

Entering 2022 well-positioned to execute on wellness strategy focused on Canadian B2B recreational cannabis and North American nutraceuticals TORONTO, March 25, 2022 (GLOBE NEWSWIRE) — Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: NXTTF), a health-tech company that leverages advancements in science and technology to build breakthrough companies that transform human wellness, today reported its financial results for year ended November 30, 2021. All financial figures are in Canadian dollars unless otherwise indicated. Fourth Quarter 2021 HighlightsWhile net revenue decreased 11% to $6.4 million in the fourth quarter ended November 30, 2021 (“Q4 2021”) (compared to $7.2 million in the same period last year (“Q4 2020”)), this was mainly due to declines in hardware sales in Europe and...

ASLAN Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

Written by Customer Service on March 25, 2022. Posted in Earnings Releases And Operating Results.

Global Phase 2b trial for eblasakimab in moderate-to-severe atopic dermatitis (AD) underway with topline data expected in the first half of 2023 New CMO appointed, adding senior global pharma experience to the leadership teamCompany maintains strong operating position with US$90.2 million in cash and cash equivalents as of December 31, 2021, runway through late 2023 Replays available for company-hosted A4 KOL series on AD landscape; next event to be held in the second quarterMENLO PARK, Calif. and SINGAPORE, March 25, 2022 (GLOBE NEWSWIRE) — ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced financial results for the fourth quarter and full year ended December 31, 2021, and provided an update...

Larimar Therapeutics Reports Fourth Quarter and Full Year 2021 Operating and Financial Results

Written by Customer Service on March 25, 2022. Posted in Earnings Releases And Operating Results.

BALA CYNWYD, Pa., March 25, 2022 (GLOBE NEWSWIRE) — Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today reported its full year 2021 operating and financial results. “The past year was highlighted by our first clinical data readouts, which demonstrated the potential of CTI-1601 to address the root cause of Friedreich’s ataxia by increasing frataxin levels in patients,” said Carole Ben-Maimon, MD, President and Chief Executive Officer of Larimar. “With these important proof-of-concept data in hand, we continue to work expeditiously to identify the best path forward through the resolution of CTI-1601’s clinical hold. Our commitment to furthering CTI-1601’s development remains steadfast, and the urgent unmet needs of patients...

Vaccitech Reports Full-Year 2021 Financial Results and Recent Corporate Developments

Written by Customer Service on March 25, 2022. Posted in Earnings Releases And Operating Results.

OXFORD, United Kingdom, March 25, 2022 (GLOBE NEWSWIRE) — Vaccitech plc (NASDAQ: VACC) today announced its financial results for the full year ended December 31, 2021 and provided an overview of the Company’s recent corporate developments. Vaccitech is a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer. “2021 was a pivotal year for Vaccitech during which we achieved a number of strategic, operational, and financial objectives, advanced multiple immunotherapeutic and prophylactic candidates in clinical development and strengthened and expanded our T cell activating discovery engine platform via the acquisition of Avidea Technologies,” commented Bill Enright, Vaccitech’s CEO. “All of this progress...

Vigil Neuroscience Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Highlights

Written by Customer Service on March 25, 2022. Posted in Earnings Releases And Operating Results.

– Completed successful initial public offering, raising $98 million in gross proceeds – – Initiated VGL101 Phase 1 trial; Phase 2 trial in ALSP patients expected to initiate in 2H 2022 – – Initiated IND-enabling studies in the small molecule Alzheimer’s disease TREM2 agonist program – – Advanced understanding and awareness of ALSP through publication of review article and launch of global patient registry – CAMBRIDGE, Mass., March 25, 2022 (GLOBE NEWSWIRE) — Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases, today announced financial results for the fourth quarter and full year ended December 31, 2021 and provided an update on recent business highlights. “This...

ARMOUR Residential REIT, Inc. Announces Guidance for April 2022 Dividend Rate Per Common Share

Written by Customer Service on March 25, 2022. Posted in Dividend Reports And Estimates.

VERO BEACH, Florida, March 25, 2022 (GLOBE NEWSWIRE) — ARMOUR Residential REIT, Inc. (NYSE: ARR and ARR-PRC) (“ARMOUR” or the “Company”) today announced guidance on the April 2022 cash dividend for the Company’s Common Stock, which maintains the current monthly dividend rate of $0.10 per Common share. April 2022 Common Stock Dividend InformationMonth Dividend Holder of Record Date Payment DateApril 2022 $0.10 April 18, 2022 April 29, 2022Certain Tax Matters ARMOUR has elected to be taxed as a real estate investment trust (“REIT”) for U.S. Federal income tax purposes. In order to maintain this tax status, ARMOUR is required to timely distribute substantially all of its ordinary REIT taxable income. Dividends paid in excess of current tax earnings and profits for the year will generally not be taxable to...

Annual Report 2021 for SP Group A/S

Written by Customer Service on March 25, 2022. Posted in Public Companies.

In 2021, SP Group realised a profit before tax of DKK 257.8 million, which is an increase of 33.0% compared to 2020. EPS increased by 28.9%. Revenue increased from DKK 2,178.2 million in 2020 to DKK 2,480.9 million in 2021, corresponding to an increase of 13.9%. In Q4 2021, SP Group realised a profit before tax and non-controlling interests of DKK 65.4 million, which is an increase of 18.9% compared to Q4 2020. Please see attachment. Unofficial version SP Group Annual Report 2021 – 25 03 22SP Group 31-12-2021

ALSTOM SA: Alstom to supply up to 40 Coradia Stream electric inter-regional trains and associated maintenance in Romania

Written by Customer Service on March 25, 2022. Posted in Public Companies.

Alstom to supply up to 40 Coradia Stream electric inter-regional trains and associated maintenance in RomaniaThe present contract for the first 20 trains and associated maintenance services for 15 years has a total value of €270 million The Coradia Stream will be the first passenger train to be provided by Alstom in Romania25 March 2022 – Alstom and the Romanian Railway Reform Authority (ARF) have signed a contract for the delivery of 20 Coradia Stream inter-regional trains and associated 15-year maintenance services. The value of the contract is estimated at €270 million. These trains will be the first passenger trains provided by Alstom for operation in Romania. The contract can be extended with the option for another 20 trains, to be confirmed by firm order from the beneficiary. Including extended maintenance on the entire fleet,...

Month: March 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals